Accessing our website tells us you are happy to receive all our cookies. However you can change your cookie settings at any time.

Privacy & Cookies

You are leaving our website

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

  • Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
  • Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
  • Privacy and security policies do not apply to third-party websites.
or Decline

Meet our leadership team

As a leadership team, our focus is on working together, leveraging the breadth and depth of expertise that exists both within the team and across the wider business. Find out more about how we think.

Find out more about our Board of Directors here.

Peter Butterfield Chief Executive Officer

Peter has over 20 years’ experience in the life sciences sector and strong leadership experience gained in a variety of contexts.

Peter was previously the company’s Deputy Chief Executive Officer and was appointed to his present office as Chief Executive Officer on the 1 May 2018 having joined Alliance in 2010 as an executive director.

He served eight years as a Board Member of the Association of the British Pharmaceutical Industry and was an integral part of the 2014 PPRS negotiation team with the UK Government. Peter joined the board of Alliance in 2010 with the acquisition of Cambridge Laboratories where he spent five years, latterly as UK Commercial Director. Prior to joining Cambridge Laboratories, Peter spent six years at GlaxoSmithKline in a variety of marketing and sales roles.

He holds an honours degree in Pharmacology from the University of Edinburgh.

Andrew Franklin Chief Financial Officer

Andrew has worked within the pharmaceutical industry for over 16 years. He joined Alliance in September 2015 from Panasonic Europe Ltd, where he was General Manager, European Tax and Accounting.

From 2010 to 2012 Andrew was Finance Director and Company Secretary of Genzyme Therapeutics Ltd, the UK & Ireland subsidiary of Genzyme Corporation. Prior to that, he was with Wyeth in a variety of senior financial positions. Andrew is a Fellow of the Institute of Chartered Accountants in England and Wales with extensive experience of financial management of international businesses, including significant prior experience in life science companies.

Andrew holds an honours degree in Civil Engineering from the University of Wales, Cardiff.

Janice Timberlake Chief People & Infrastructure Officer

Janice is a Fellow of CIPD with over 25 years’ experience in HR roles, having previously held senior roles in My Travel plc and National Environment Research Council.

Janice is also a Non-executive Director and Trustee of Plymouth Marine Laboratory Ltd, where she chairs the Remuneration Committee.

Janice graduated in Geography from Hull University, and has been with Alliance since 2011.

Stephen Kidner Chief Scientific & Operations Officer

Stephen has over 20 years’ sector experience in product development and supply, having previously held senior roles at Wyeth (now Pfizer) and Mundipharma International. Stephen joined Alliance in 2013.

He graduated in Chemistry from Swansea University, holds an MSc in Pharmaceutics from Manchester University and an MBA from The Open University.

Alex Duggan Chief Commercial Officer

Alex has over 20 years’ experience in pharma and business management. Alex joined Alliance in 2014.

He founded his own consumer healthcare business in 1996 and won a Queen’s Award for International Trade in 2003. He is a Board Member of the PAGB the Proprietary Association of Great Britain.

Alex graduated in Archaeology from Newcastle University.

Dan Thomas Chief Corporate Development Officer

Dan has over 20 years’ international healthcare experience, and has previously worked in Canada, Germany and France.

Since joining Alliance in 2006, Dan has led Alliance’s M&A and licensing activity, completing more than 20 deals. In 2011, Dan won the Pharma Licensing Group (PLG)/Astra Zeneca BD Executive of the Year award and he is currently Vice-Chair of the Board of the UK PLG.

Dan graduated in Applied Biochemistry from Brunel University.

Scroll to see more